Understanding how SARS-CoV-2 vaccines affect immune responses
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
This study is looking at how well the COVID-19 vaccine and natural infection help your immune system fight the virus, by checking the types of antibodies in your blood and how long they last, so we can better understand protection against COVID-19.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11144632 on NIH RePORTER |
What this research studies
This research investigates the immune responses generated by SARS-CoV-2 vaccination and natural infection in humans. It aims to identify specific antibody profiles that correlate with protection against COVID-19, as well as to understand how long these immune responses last. By analyzing blood samples from vaccinated and convalescent individuals, the study seeks to determine the effectiveness and durability of the antibodies produced. This information could help improve vaccine strategies and inform public health responses to the pandemic.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have received a SARS-CoV-2 vaccine or those who have recovered from a COVID-19 infection.
Not a fit: Patients who have not been vaccinated against SARS-CoV-2 and have not had a prior COVID-19 infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and better understanding of immunity against COVID-19.
How similar studies have performed: Other research has shown promising results in understanding immune responses to vaccines, making this approach both relevant and potentially impactful.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Barouch, Dan H. — Beth Israel Deaconess Medical Center
- Study coordinator: Barouch, Dan H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.